How do you assess the risk of cardiotoxicity from HER2+ agents?

The standard risk factors for cardiac dysfunction from Her2+ therapy are age, prior chest radiation, prior cardiotoxic therapy, baseline LVEF, and co-morbidities such as diabetes, dyslipidemia, obesity, hypertension, atrial fibrillation/flutter, and coronary artery disease. In addition to these, som...